TY - JOUR
T1 - Synthesis and characterization of a 13-member macrocycle functionalized by tyramine arms: Complexation with Cu2+and antioxidant capacity
AU - López-Martínez, Luis Miguel
AU - Santacruz-Ortega, Hisila
AU - Navarro, Rosa Elena
AU - Inoue, Motomichi
AU - Sugich-Miranda, Rocío
AU - Hernández-Paredes, Javier
AU - Castillo, Ivan
AU - Sotelo-Mundo, Rogerio R.
PY - 2017/5/8
Y1 - 2017/5/8
N2 - © 2016 Elsevier Ltd A new macrocycle bearing tyramine arms through amide linkages, 2,2′-(2,9-dioxo-1,4,7,10-tetraazacyclotridecane-4,7-diyl)bis(N-(4-hydroxyphenethyl)acetamide) abbreviated as L13Tyra, has been synthesized with amide-coupling agents in a microwave reactor. This macrocycle involves two potential metal-coordinating and bioactive sites, i.e., the tetraaza-macrocyclic ring (with a low basicity of the amino nitrogen) and the pendant phenol arms (with a small pKa8.6). The Cu2+complex has different compositions in solid and in solution. An X-ray crystal study shows that a mononuclear complex [Cu(L13Tyra – 2H)]0is formed with a square coordination of two deprotonated amide nitrogen and two amino nitrogen atoms of the macrocyclic ring; a carbonyl oxygen atom from a pendant arm occupies an axial site to construct a square pyramid. UV–Vis spectrometric titrations in aqueous solutions indicate the formation of a binuclear complex [Cu2(L13Tyra – 4H)(H2O)x]0in which phenolate oxygen atoms of the tyramine arms coordinate a Cu2+ion in addition to the coordination of the macrocyclic chelate; such a binuclear structure is maintained only in solution. The uncoordinated ligand has a high antioxidant capacity with a TEAC (Trolox equivalent antioxidant capacity) assay comparable to that of ascorbic acid, thanks to the phenolic OH of the tyramine arms. Copper(II) ion works as an inhibitor against the activity; the TEAC assay of the binuclear complex is as small as one-twentieth that of the uncoordinated ligand. Antiproliferative and cytotoxic assays with normal and cancer cell lines show no toxicity for both the ligand and its Cu2+complex.
AB - © 2016 Elsevier Ltd A new macrocycle bearing tyramine arms through amide linkages, 2,2′-(2,9-dioxo-1,4,7,10-tetraazacyclotridecane-4,7-diyl)bis(N-(4-hydroxyphenethyl)acetamide) abbreviated as L13Tyra, has been synthesized with amide-coupling agents in a microwave reactor. This macrocycle involves two potential metal-coordinating and bioactive sites, i.e., the tetraaza-macrocyclic ring (with a low basicity of the amino nitrogen) and the pendant phenol arms (with a small pKa8.6). The Cu2+complex has different compositions in solid and in solution. An X-ray crystal study shows that a mononuclear complex [Cu(L13Tyra – 2H)]0is formed with a square coordination of two deprotonated amide nitrogen and two amino nitrogen atoms of the macrocyclic ring; a carbonyl oxygen atom from a pendant arm occupies an axial site to construct a square pyramid. UV–Vis spectrometric titrations in aqueous solutions indicate the formation of a binuclear complex [Cu2(L13Tyra – 4H)(H2O)x]0in which phenolate oxygen atoms of the tyramine arms coordinate a Cu2+ion in addition to the coordination of the macrocyclic chelate; such a binuclear structure is maintained only in solution. The uncoordinated ligand has a high antioxidant capacity with a TEAC (Trolox equivalent antioxidant capacity) assay comparable to that of ascorbic acid, thanks to the phenolic OH of the tyramine arms. Copper(II) ion works as an inhibitor against the activity; the TEAC assay of the binuclear complex is as small as one-twentieth that of the uncoordinated ligand. Antiproliferative and cytotoxic assays with normal and cancer cell lines show no toxicity for both the ligand and its Cu2+complex.
U2 - 10.1016/j.poly.2016.10.028
DO - 10.1016/j.poly.2016.10.028
M3 - Article
SN - 0277-5387
SP - 438
EP - 448
JO - Polyhedron
JF - Polyhedron
ER -